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Lanktree et al., page 6
Anthropometry is the measurement of humans and is used
to understand physical variation between people. Popular-
ized in the late 1800s, the collection of biometric data
began as a means to catch repeat criminals. By compiling
lists of measurements such as height, cheek width, arm
span, foot length, etc. of people convicted of a crime,
police could catch the same crook again despite the use
of an alias. Like many new technologies, anthropometry
was soon used to discriminate different ‘‘races’’ and catego-
rize criminals on the basis of physical characteristics rather
than behavior. Today, human measurement is a standard
practice in clinics around the world. Birth weight, body
length (height), and foot size can all be plotted against
standard curves to determine how one compares to the
average. Such measurements are also important for the
clothing, toy, and automobile industries, to name a few.
In this issue, Lanktree and colleagues perform a search
for genetic loci contributing to the variability of human
height. Although height is certainly influenced by envi-
ronment and nutrition, genetics is also a strong determi-
nant of adult height. Like other complex traits, many
different genetic factors are thought to combine to influ-
ence final height. By looking at nearly 50,000 different
SNPs in more than 100,000 people, Lanktree and col-
leagues identify a number of rare variants associated
with human height. They conclude that using SNP arrays
with dense coverage will uncover variants associated with
many more complex traits.Radical Hearing-Loss Mutations
Ahmed et al., page 19
When we eat a meal, the mitochondria in our bodies kick
into action. Nutrients become oxidized (typically meaning
that electrons are lost), whereas other molecules become
reduced (they pick up the extra electrons), reducing their
oxidation state. These so-called redox reactions are crucial
for metabolizing our food and keeping our bodies running
properly. Within the mitochondria, the energy released
from a redox reaction is used to make ATP, the energy
unit of our cells. Although these processes are necessary,
they also lead to a negative side effect: free radicals. Free
radicals are known to damage cells and thought to be1Science Editor, AJHG; 2Deputy Editor, AJHG
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Thinvolved in the aging process. Much research is focused
on improving the body’s ability to rid itself of these free
radicals. Methionine sulfoxide is one such free radical.
Methionine is a common residue in proteins found in
the food we consume. During metabolism, methionine
becomes oxidized into methionine sulfoxide. However,
methionine sulfoxide derivatives quickly become free radi-
cals that can damage the cell. Fortunately, our bodies have
a system for controlling this: methionine sulfoxide reduc-
tases (MSRs) change methionine sulfoxide back to methio-
nine. Different MSRs perform this task in different tissues.
MSRB3 contains isoforms that target methionine sulfoxide
in mitochondria. In this issue, Ahmed and colleagues
identify MSRB3 mutations in eight families with auto-
somal-recessive nonsyndromic hearing loss linked to the
DFNB74 locus. This study conclusively defines mutations
in MSRB3 as causative of DNFB74 and highlights the role
of mitochondria in hearing loss.On a Scale from 0 to PTEN
Tan et al., page 42
PTEN hamartoma tumor syndrome (PHTS) refers to
a collection of heterogeneous phenotypes that are caused
by germline mutations in PTEN. Some individuals with
PTEN mutations have clinical features that are classified
as Cowden syndrome, but not all people with Cowden
syndrome have PTEN mutations. Likewise, the pediatric
syndrome Bannayan-Riley-Ruvalcaba can also be due to
PTENmutations but is similarly genetically heterogeneous.
Some of the common features among these patients can
include macrocephaly and cancers, as well as skin, neuro-
logic, and gastrointestinal manifestations. Having such
a mix of overlapping disease presentations can make diag-
noses and genetic counseling complicated, and the ability
to identify patients who are likely to carry PTENmutations
would be advantageous. Previous analyses of patients with
and without PTENmutations have led to the development
of criteria that can be used to predict the genotype of
patients, but there are some limitations to the current
guidelines. In this issue, Tan et al. present a scoring system
that they have established on the basis of the clinical geno-
type and phenotype data that they collected from a large
data set of patients. They derive criteria for pediatric and
adult cases and demonstrate how these lead to improved
predictions of PTEN-mutation status over those madeGenetics. All rights reserved.
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with the current guidelines. The authors also evaluate the
correlation between disease score and the levels of proteins
in the PTEN pathway.Duplications and Fusions
Klopocki et al., page 70
Syntosis is the abnormal fusion of neighboring bones.
It typically occurs during development and is sometimes
associated with a syndrome. Bones are formed by two
different processes in the body. The appendicular skeleton
and portions of the axial skeleton form via endochondrial
ossification. In this process, a cartilage template is replaced
by ossified bone. The majority of the axial skeleton
forms by another means, intramembraneous ossification,
which lacks the cartilage template. Interestingly, syntoses
can take place in skeletal elements, arising by either form
of ossification. Craniosyntosis is an example of syntosis
occurring during intramembranous ossification and results
in the premature fusion of skull bones. Syndactyly, or the
joining of digits, is an example of syntosis occurring during
endochondrial ossification. Unlike craniosyntosis, syndac-
tyly may not involve the bones themselves, but rather just
the connective tissue surrounding the bones. If this is
the case, the phenotype is called syndactyly type I. The
genetics underlying syntoses have been as elusive as the
biological processes leading to them. In this issue, Klopocki
and colleagues identify duplications in a regulatory region
of IHH leading to both craniosyntosis and syndactyly in
three separate families. IHH encodes a morphogen known
to play a role in endochondrial ossification osteoclast2 The American Journal of Human Genetics 88, 1–2, January 7, 2011differentiation. Finding the specific role for this protein
in cranial and digit development will aid in our under-
standing of the complex process of syntosis.In Search of What Is Missing
Yang et al., page 76
Missing heritability is what everyone is looking for these
days. If the genetic components of complex traits are as
large as they are supposed to be, then why do the variants
identified as being associated with the traits explain so
little of the heritability? What hasn’t been found yet?
Are there lots of rare variants with large effects out there?
Do a bunch of common variants have such small effects
alone that they can’t be detected with single-SNP tech-
niques? Is it a mix of both, or is something altogether
different going on? Yang and colleagues have developed
a tool that will hopefully assist in figuring out the answers
to these questions. Their method involves evaluating the
combined effects of all the SNPs on the genotyping arrays
for an association with a complex trait. By doing this, the
authors bypass the problem of common SNPs having
effect sizes that are too small to be measured in reasonably
sized data sets. The authors are then able to estimate the
variance explained by all autosomal SNPs and by SNPs
on the X chromosome, as well as to measure genetic relat-
edness and inbreeding coefficients. In this issue, the
authors discuss the incorporation of their methods into
a software tool called Genome-wide Complex Trait
Analysis, GCTA, and demonstrate the useful functions
available.
